Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience

This study was done to assess the overall response rate of imatinib mesylate in local patients with chronic myeloid leukaemia. A total of 69 patients were recruited with male/female ratio of 7:3. Of the 69 patients; 35% were in the chronic phase, 41% were in the accelerated phase, 17% were in blast...

Full description

Saved in:
Bibliographic Details
Main Authors: Bee, P.C., Gan, G.G., Teh, A., Haris, A.R.
Format: Article
Published: Malaysian Medical Association 2006
Subjects:
Online Access:http://eprints.um.edu.my/12019/
http://www.e-mjm.org/2006/v61n5/Chronic_Myeloid_Leukemia.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!